Novartis and BMS filed an emergency motion with the federal appeals court in Washington, D.C. to appeal a recent ruling on drugmaker 340B rebates.

In Emergency Motion, Novartis and BMS Urge Appellate Court to Fast-Track Their Appeals of 340B Rebate Ruling

June 5, 2025 William Newton, Associate Editor/Senior Writer Views

Novartis and Bristol Myers Squibb (BMS) are asking a federal appeals court to expedite their challenge to a recent ruling [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!